Replies to post #391450 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

Like hell we're paying him in shares.

Even Nasrat HIMSELF was happy this summer to inform shareholders that dilution will stop with his salary.

We're going to pay him in CASH, and if necessary, cash OVER TIME with a REASONABLE interest rate.

Elite has enough cash that they said they're going to write out a CHECK for the following within the next 4-7 months:

-Mikah profit splits
-Nasrat Hakim Promissory Note
-Davis Caskey Promissory Note

[HGilS]

In My opinion, we should NOT use the 400 Million authorized shares at the current prices...

This would be selling off the company at very low price. We should forget those shares and dissolve the agreement we had with Lincoln Partners.

Let's wait the company is making more money day by day - March is 3 months away...

Using the 400 million shares would bring 60 Million - and dilute the company by 40%...

Even using 40 Million shares and get 6 Million would be a waste - as we will be at $1 by end of 2024 - mark my words.
.

[mrwrn2010]

Agree, BUT, also think about this. I think it’s been at least 2 quarterly filings now where they’ve said they don’t even plan to take the optional second year extensions on either the Nasrat credit line or the Caskey credit line (believe it was both). So, therefore, taking that and our current position into account - revenues, profits, Burel on Jan 1, we *shouldn’t* have any more significant dilution going forward, right?